Following last week's report in the New England Journal of Medicine on a new method of using genetic testing to determine the best coumadin dosage for patients, the Boston Globe examines the potential of personalized medicines. The report examines similar experiments being pursued by cancer researchers and doctors looking for better ways to treat asthma. Story